<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01030523</url>
  </required_header>
  <id_info>
    <org_study_id>YA-SHO-0002</org_study_id>
    <nct_id>NCT01030523</nct_id>
  </id_info>
  <brief_title>Study on ASTRA TECH Implant System, Short Implants (OsseoSpeed™) Compared to Standard Length Implants (OsseoSpeed™) With Bone Substitution</brief_title>
  <official_title>Short Implants - An Alternative to Bone Grafting?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dentsply Sirona Implants</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dentsply Sirona Implants</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study, with the ASTRA TECH Implant System, is comparing short implants (OsseoSpeed™) to&#xD;
      standard length implants (OsseoSpeed™) with bone substitution.&#xD;
&#xD;
      The hypothesis is that the use of short implants in posterior maxilla with inadequate bone is&#xD;
      as safe and predictable as placing standard length implants in combination with bone&#xD;
      augmentation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 2009</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implant Survival Rate</measure>
    <time_frame>5 years after permanent restoration</time_frame>
    <description>Any implant that is removed after implant placement will be considered a failure, whatever the reason for removal. Implant survival will be evaluated clinically and radiographically by counting the number of remaining implants. Implant survival rate will be calculated by dividing the number of non-failures by the number of installed implant.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Marginal Bone Level Alterations</measure>
    <time_frame>5 years after permanent restoration</time_frame>
    <description>Marginal bone level will be determined from radiographs and expressed as the distance from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant. Marginal bone level expressed in millimetres at the 5 year follow-up visit will be compared to values obtained at delivery of permanent restoration. Positive value denotes gain of bone. Negative value denotes loss of bone.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Condition of Periimplant Mucosa; Bleeding on Probing (BoP)</measure>
    <time_frame>5 years after permanent restoration</time_frame>
    <description>Bleeding on Probing will be evaluated at four aspects per implant, i.e. mesially, distally, buccally and palatinally by using a periodontal probe. BoP will be recorded as presence or absence (Yes or No) of bleeding when probing to the bottom of the pocket. The proportion of surfaces that show presence of bleeding will be calculated and presented on a subject level..</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Condition of Periimplant Mucosa: Probing Pocket Depth (PPD)</measure>
    <time_frame>5 year after permanent restoration</time_frame>
    <description>PPD will be measured as the distance from the mucosal margin to the bottom of the probeable pocket in mm. A mean value will be calculated for each implant as well as for each subject. PPD changes in millimetres at the 5 year follow-up visit will be compared to values obtained at delivery of permanent restoration. Negative value denotes deeper pocket depth.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Jaw, Edentulous, Partially</condition>
  <arm_group>
    <arm_group_label>Short Implants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long Implants</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ASTRA TECH Implants System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm)</intervention_name>
    <description>ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm)</description>
    <arm_group_label>Short Implants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ASTRA TECH Implant System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm)</intervention_name>
    <description>ASTRA TECH Implant System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm)</description>
    <arm_group_label>Long Implants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provision of informed consent&#xD;
&#xD;
          -  Aged 20-75 years at enrolment&#xD;
&#xD;
          -  History of edentulism in the study area of at least four months&#xD;
&#xD;
          -  In need for 1-4 implants in either side of the posterior maxilla (premolar and molar&#xD;
             region)&#xD;
&#xD;
          -  Neighboring tooth/teeth to the planned implant/s must have natural root(s) or implant&#xD;
             supported restoration, with absence of pathology or excessive bone loss, as judged by&#xD;
             the investigator&#xD;
&#xD;
          -  Presence of natural tooth/teeth, partial prosthesis and/or implants in the opposite&#xD;
             jaw in contact with the planned crown/s&#xD;
&#xD;
          -  Deemed by the investigator to have a bone height between 5 and 7 mm and a bone width&#xD;
             of a minimum of 6 mm&#xD;
&#xD;
          -  Deemed by the investigator as likely to present an initially stable implant situation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unlikely to be able to comply with study procedures, as judged by the investigator&#xD;
&#xD;
          -  Earlier bone graft procedures in the study area&#xD;
&#xD;
          -  Uncontrolled pathologic processes in the oral cavity&#xD;
&#xD;
          -  Known or suspected current malignancy&#xD;
&#xD;
          -  History of radiation therapy in the head and neck region&#xD;
&#xD;
          -  History of chemotherapy within 5 years prior to surgery&#xD;
&#xD;
          -  Systemic or local disease or condition that could compromise post-operative healing&#xD;
             and/or osseointegration&#xD;
&#xD;
          -  Uncontrolled diabetes mellitus&#xD;
&#xD;
          -  Corticosteroids, iv bisphosphonates or any other medication that could influence&#xD;
             post-operative healing and/or osseointegration&#xD;
&#xD;
          -  Smoking more than 10 cigarettes/day&#xD;
&#xD;
          -  Bruxism&#xD;
&#xD;
          -  Present alcohol and/or drug abuse&#xD;
&#xD;
          -  Involvement in the planning and conduct of the study (applies to both Astra Tech staff&#xD;
             and staff at the study site)&#xD;
&#xD;
          -  Previous enrolment in the present study&#xD;
&#xD;
          -  Simultaneous participation in another clinical study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Hämmerle, Prof. Dr. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zentrum für Zahn-, Mund- und Kieferheilkunde der Universität Zürich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Oral Rehabilitation, Skeletal Development and Biomaterials, University of Connecticut, School of Dental Medicine</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ärztegesellschaft für Zahn- Mund- und Kieferheilkunde, Akademie für Orale Implantologie: Fürhauser, Haas, Mailath-Pokorny &amp; Watzek OG</name>
      <address>
        <city>Wien</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aesthetic Dent</name>
      <address>
        <city>Szczecin</city>
        <zip>P-71-403</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Facultad de Medicina y Odontologia, Universidade de Santiago de Compostela</name>
      <address>
        <city>Santiago de Compostela</city>
        <zip>ES-15782</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentrum für Zahn-, Mund- und Kieferheilkunde der Universität Zürich</name>
      <address>
        <city>Zürich</city>
        <zip>CH-8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Thoma DS, Haas R, Tutak M, Garcia A, Schincaglia GP, Hämmerle CH. Randomized controlled multicentre study comparing short dental implants (6 mm) versus longer dental implants (11-15 mm) in combination with sinus floor elevation procedures. Part 1: demographics and patient-reported outcomes at 1 year of loading. J Clin Periodontol. 2015 Jan;42(1):72-80. doi: 10.1111/jcpe.12323. Epub 2014 Dec 26.</citation>
    <PMID>25418606</PMID>
  </results_reference>
  <results_reference>
    <citation>Schincaglia GP, Thoma DS, Haas R, Tutak M, Garcia A, Taylor TD, Hämmerle CH. Randomized controlled multicenter study comparing short dental implants (6 mm) versus longer dental implants (11-15 mm) in combination with sinus floor elevation procedures. Part 2: clinical and radiographic outcomes at 1 year of loading. J Clin Periodontol. 2015 Nov;42(11):1042-51. doi: 10.1111/jcpe.12465. Epub 2015 Nov 27.</citation>
    <PMID>26425812</PMID>
  </results_reference>
  <results_reference>
    <citation>Pohl V, Thoma DS, Sporniak-Tutak K, Garcia-Garcia A, Taylor TD, Haas R, Hämmerle CH. Short dental implants (6 mm) versus long dental implants (11-15 mm) in combination with sinus floor elevation procedures: 3-year results from a multicentre, randomized, controlled clinical trial. J Clin Periodontol. 2017 Apr;44(4):438-445. doi: 10.1111/jcpe.12694. Epub 2017 Mar 6.</citation>
    <PMID>28081288</PMID>
  </results_reference>
  <results_reference>
    <citation>Thoma DS, Haas R, Sporniak-Tutak K, Garcia A, Taylor TD, Hämmerle CHF. Randomized controlled multicentre study comparing short dental implants (6 mm) versus longer dental implants (11-15 mm) in combination with sinus floor elevation procedures: 5-Year data. J Clin Periodontol. 2018 Dec;45(12):1465-1474. doi: 10.1111/jcpe.13025. Epub 2018 Nov 25.</citation>
    <PMID>30341961</PMID>
  </results_reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>December 10, 2009</study_first_submitted>
  <study_first_submitted_qc>December 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2009</study_first_posted>
  <results_first_submitted>August 20, 2020</results_first_submitted>
  <results_first_submitted_qc>August 20, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 7, 2020</results_first_posted>
  <last_update_submitted>August 20, 2020</last_update_submitted>
  <last_update_submitted_qc>August 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Jaw, Edentulous</mesh_term>
    <mesh_term>Jaw, Edentulous, Partially</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Short Implants</title>
          <description>ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm)</description>
        </group>
        <group group_id="P2">
          <title>Long Implants</title>
          <description>ASTRA TECH Implants System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Implant failure</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Short Implants</title>
          <description>ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm)</description>
        </group>
        <group group_id="B2">
          <title>Long Implants</title>
          <description>ASTRA TECH Implants System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="101"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.2" spread="12.88"/>
                    <measurement group_id="B2" value="50.5" spread="14.05"/>
                    <measurement group_id="B3" value="50.4" spread="13.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Implant Survival Rate</title>
        <description>Any implant that is removed after implant placement will be considered a failure, whatever the reason for removal. Implant survival will be evaluated clinically and radiographically by counting the number of remaining implants. Implant survival rate will be calculated by dividing the number of non-failures by the number of installed implant.</description>
        <time_frame>5 years after permanent restoration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Short Implants</title>
            <description>ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm)</description>
          </group>
          <group group_id="O2">
            <title>Long Implants</title>
            <description>ASTRA TECH Implants System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm)</description>
          </group>
        </group_list>
        <measure>
          <title>Implant Survival Rate</title>
          <description>Any implant that is removed after implant placement will be considered a failure, whatever the reason for removal. Implant survival will be evaluated clinically and radiographically by counting the number of remaining implants. Implant survival rate will be calculated by dividing the number of non-failures by the number of installed implant.</description>
          <units>Implants</units>
          <param>Count of Units</param>
          <units_analyzed>Implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="67"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66"/>
                    <measurement group_id="O2" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Marginal Bone Level Alterations</title>
        <description>Marginal bone level will be determined from radiographs and expressed as the distance from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant. Marginal bone level expressed in millimetres at the 5 year follow-up visit will be compared to values obtained at delivery of permanent restoration. Positive value denotes gain of bone. Negative value denotes loss of bone.</description>
        <time_frame>5 years after permanent restoration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Short Implants</title>
            <description>ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm)</description>
          </group>
          <group group_id="O2">
            <title>Long Implants</title>
            <description>ASTRA TECH Implants System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm)</description>
          </group>
        </group_list>
        <measure>
          <title>Marginal Bone Level Alterations</title>
          <description>Marginal bone level will be determined from radiographs and expressed as the distance from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant. Marginal bone level expressed in millimetres at the 5 year follow-up visit will be compared to values obtained at delivery of permanent restoration. Positive value denotes gain of bone. Negative value denotes loss of bone.</description>
          <units>Millimetre (implant level)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" spread="0.535"/>
                    <measurement group_id="O2" value="-0.18" spread="0.959"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Condition of Periimplant Mucosa; Bleeding on Probing (BoP)</title>
        <description>Bleeding on Probing will be evaluated at four aspects per implant, i.e. mesially, distally, buccally and palatinally by using a periodontal probe. BoP will be recorded as presence or absence (Yes or No) of bleeding when probing to the bottom of the pocket. The proportion of surfaces that show presence of bleeding will be calculated and presented on a subject level..</description>
        <time_frame>5 years after permanent restoration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Short Implants</title>
            <description>ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm)</description>
          </group>
          <group group_id="O2">
            <title>Long Implants</title>
            <description>ASTRA TECH Implants System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm)</description>
          </group>
        </group_list>
        <measure>
          <title>Condition of Periimplant Mucosa; Bleeding on Probing (BoP)</title>
          <description>Bleeding on Probing will be evaluated at four aspects per implant, i.e. mesially, distally, buccally and palatinally by using a periodontal probe. BoP will be recorded as presence or absence (Yes or No) of bleeding when probing to the bottom of the pocket. The proportion of surfaces that show presence of bleeding will be calculated and presented on a subject level..</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Condition of Periimplant Mucosa: Probing Pocket Depth (PPD)</title>
        <description>PPD will be measured as the distance from the mucosal margin to the bottom of the probeable pocket in mm. A mean value will be calculated for each implant as well as for each subject. PPD changes in millimetres at the 5 year follow-up visit will be compared to values obtained at delivery of permanent restoration. Negative value denotes deeper pocket depth.</description>
        <time_frame>5 year after permanent restoration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Short Implants</title>
            <description>ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm)</description>
          </group>
          <group group_id="O2">
            <title>Long Implants</title>
            <description>ASTRA TECH Implants System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm)</description>
          </group>
        </group_list>
        <measure>
          <title>Condition of Periimplant Mucosa: Probing Pocket Depth (PPD)</title>
          <description>PPD will be measured as the distance from the mucosal margin to the bottom of the probeable pocket in mm. A mean value will be calculated for each implant as well as for each subject. PPD changes in millimetres at the 5 year follow-up visit will be compared to values obtained at delivery of permanent restoration. Negative value denotes deeper pocket depth.</description>
          <units>Millimetre</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2568" spread="0.912"/>
                    <measurement group_id="O2" value="-0.4307" spread="1.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Short Implants</title>
          <description>ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm)</description>
        </group>
        <group group_id="E2">
          <title>Long Implants</title>
          <description>ASTRA TECH Implants System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Blood cancer (led to death)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Aorta stent (hospitalization)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Chest pain during dental surgery procedure (hospitalization)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Car accident, back injury (hospitalization and Med./surg. intervention to prevent perm. impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Benign medular tumour (hospitalization)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Breast cancer (hospitalization)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Kidney stone (hospitalization)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Knee replacement surgery (hospitalization)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Swollen after oral surgery</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Screw loosening</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="50"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Crown loosening</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Manager of Global Clinical Research</name_or_title>
      <organization>Dentsply Sirona Implants</organization>
      <phone>+46313763500</phone>
      <email>ClinicalResearchMolndal@dentsplysirona.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

